Holding(s) in Company

Summary by AI BETAClose X

Gresham House Asset Management Ltd notified that it crossed the 20% major-holding threshold in Diaceutics, increasing its direct holding to 21.59% (18,415,527 voting rights) on 12/11/2026, up from 19.01% previously; notification was filed on 16/11/2026. The stake is entirely direct with no financial instruments reported, which materially increases Gresham House's voting influence and could affect shareholder outcomes or strategic decisions.

Disclaimer*

Companies

Diaceutics (DXRX)
UK 100

Latest directors dealings